Josh Allen

Josh Allen

Company: Chimerix Inc

Job title: CTO


9:00am -12:00pm Morning Workshop A: Optimizing Clinical Trial Design: From Biomarker Selection to Imaging to Endpoints 9:00 am - 12:00 pm

Many therapies show huge promise for glioblastoma treatment, but few have been successful in clinical trials. A key challenge associated with drug discovery in the space is designing efficient and effective trials, which grows increasingly more difficult with the adoption of combination approaches. This workshop will cover: Formulating an adaptive trial design Next generation combination…Read more

day: Pre-conference Workshop Day

ONC201 in Recurrent H3 K27M-mutant Diffuse Midline Glioma 2:45 pm

Overview of ONC201 discovery and early clinical development Review of efficacy signal refinement for ONC201 toward H3 K27M-mutant glioma Summary of ONC201 efficacy it recurrent H3 K27M-mutant diffuse midline gliomaRead more

day: Conference Day One

A Hanson Wade Group Company

© Copyright 2023 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.